Q2FY26 - Consolidated Earnings Preview
The Q2FY26 earnings season was marked with interesting events: 1) Mixed trends in US policies, 2) Indian currency depreciation, 3) Slower uptick in...
457 Views
Q2FY26 Earnings Preview - Pharma & Healthcare
We expect pharmaceutical companies under our coverage to deliver a steady performance in Q2FY26, with aggregate revenue rising by 7.4% YoY and 2.7%...
355 Views
Q1FY26 - Consolidated Earnings Preview
Some breather is expected in Q1FY26 on account of sequential improvement in some of the pockets of high-frequency indicators.
261 Views
Top Conviction Ideas - “Pharmaceutical & Hospitals” - Q4FY25 Pharma Review
The pharmaceutical universe under our coverage reported Q4FY25 growth of 12.3% YoY and 2.3% QoQ, driven by strong growth in the India business...
232 Views
Q4FY25 Earnings Preview - Pharma & Healthcare
Moreover, adjusted PAT is expected to grow by 8.7% YoY and decrease by 7.9% QoQ. Domestic formulations and niche launches in the US market will...
270 Views